Observational study on chronic kidney disease in children
Official title: Chronic Kidney Disease in Children Prospective Cohort Study (CKiD)
Run by Johns Hopkins Bloomberg School of Public Health · NCT00327860 · Data updated 2026-11-12
This study looks at how chronic kidney disease affects children's health and growth to see what factors might lead to kidney problems as they grow up.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 6 Months to 22 Years |
| Sex | All |
| Enrollment | 1300 (estimated) |
| Sponsor | Johns Hopkins Bloomberg School of Public Health Academic / other |
| Drugs / interventions | trastuzumab, chemotherapy |
| Locations | 2 sites (Kansas City, Missouri and 1 other locations) |
| Status | Recruiting |
| Started | October 2003 |
| Main results expected | July 2028 |
| Study ends | July 2028 |
| Registry record updated | April 17, 2026 |
| Trial ID | NCT00327860 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are children aged 1 to 22 years with chronic kidney disease who are regularly seen by a pediatric nephrologist.
✕Probably not a fit
Patients with solid organ transplants, recent cancer treatment, or HIV may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
The Chronic Kidney Disease in Children Prospective Cohort Study (CKiD) is an observational study aimed at understanding the risk factors for decline in kidney function among children with chronic kidney disease (CKD). Conducted by a collaboration of prominent institutions, the study collects data on various health outcomes, including cardiovascular health, neurocognitive function, and growth failure. It involves multiple cohorts of children and young adults, with a focus on how CKD impacts their overall health and transition to adult care. The study has been ongoing since 2003 and aims to provide insights that could improve management and outcomes for affected children.
Why it matters
Potential benefit: If successful, this study could lead to improved understanding and management strategies for children with chronic kidney disease, potentially enhancing their long-term health outcomes.
How similar studies have gone: Other studies focusing on chronic kidney disease in children have shown promising results, indicating that this approach is supported by previous research.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age between 1 and 16 years (before 17th birthday) for Cohorts 1 and 2; age between 6 months and 16 years (before 17th birthday) for Cohort 3; age between 16 to 22 years (before 23rd birthday) for Cohort 4 * Estimated (based on SCr) Schwartz GFR between 30 and 90 ml/min\|1.73m2 for Cohort 1 OR an estimated GFR between 45 and 90 ml/min\|1.73m2 based on the updated Schwartz formula for Cohort 2; an estimated GFR ≤60 based on the CKiD Under 25 estimating equation (U25eGFR) OR KRT experience (dialysis or transplant) for Cohort 4 * Willingness and ability to provide informed consent and assent * For Cohort 3, children with non-glomerular diagnosis and duration of kidney disease less than 5 years will be enrolled. Exclusion Criteria: * Solid organ (other than kidney), bone marrow or stem cell transplantation * Cancer diagnosis and receiving treatment or within 12 months post completion of treatment * Ongoing monitoring for cardiotoxic effects of prior chemotherapy or targeted cancer therapies (e.g., anthracyclines, trastuzumab) * HIV infection with detectable viral load despite current antiretroviral therapy * Current pregnancy or pregnancy within past twelve months * Inability to complete major data collection procedures * Not fluent in English or Spanish * Plans to move out of area of any participating CKiD site (families can be transferred to another CKiD site if the family moves) * Existing moderate to severe congenital structural heart disease * Genetic syndromes involving the central nervous system (e.g., Downs syndrome) * History of severe to profound intellectual disability (i.e., Intelligence Quotient (IQ)\<40, significant impairment in adaptive function and/or inability to independently execute self-care skills) * For cohort 3, children who are expected to receive renal replacement therapy within 6 months of date of enrollment will not be recruited
Where it's running
-
Children's Mercy Kansas City
Kansas City, Missouri, United States Recruiting -
The Children's Hospital of Philadelphia
Philadelphia, Pennsylvania, United States Recruiting
Study contacts
- Principal investigator: Susan Furth, MD, PhD — Children's Hospital of Philadelphia
- Study coordinator: Susan Furth, MD, PhD
- Email: FurthS@email.chop.edu
- Phone: 215-590-2449
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Observational look at how Kremezin works in adults with advanced chronic kidney disease
This study tests whether Kremezin helps adults with advanced kidney disease when used as part of routine care, by tracking safety and kidney function over up to 48 weeks.
-
Kidney and Heart Health in Adults with Type 2 Diabetes and CKD Treated with Semaglutide in China
This study tests whether semaglutide injections help kidney and heart health in adults with type 2 diabetes and chronic kidney disease.
-
High BMI and periodontitis in Thai adults under 60
This study tests how common high BMI and periodontitis are among Thai adults aged 18–59 and what factors are linked to them.
-
Optimised Cardio-Renal Care for CKD and heart disease
This study tests whether a specialised Cardio-Renal Clinic can improve heart and kidney health and quality of life for adults with chronic kidney disease and cardiovascular disease.
-
NMR-based Risk Test and Digital Health Support for midlife adults in Eloisa
This study tests whether an NMR metabolomics risk test can guide tailored digital health programs for midlife adults at risk of diabetes, heart disease, stroke, kidney disease, or fatty liver.
-
Arterial stiffness in children and young people with CKD and hypertension
This study will test whether arterial stiffness is higher in children and young people with chronic kidney disease and high blood pressure compared with their peers, using a one-time assessment and follow-up for those with high BP.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.